由CDK4和CDK6阻断引起的DNA损伤通过cGAS-STING通路触发了抗瘤免疫反应
Huimin Fan1, Wancheng Liu2, Yanqiong Zeng1
1National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.
CDK4/6抑制剂通过STING通路增强抗瘤免疫力. 阻断CDK4/6会增加DNA损伤,激活STING和干扰素反应,导致瘤抑制.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 循环素依赖性激酶4和6 (CDK4/6) 调节细胞循环,它们的抑制剂是已知的抗癌药物.
- 过度表达CDK4/6与患者的生存率差以及人类癌症中T细胞透率降低相关.
研究的目的:
- 研究通过CDK4/6阻断抑制瘤的STING依赖性免疫机制.
- 阐明CDK4/6抑制如何影响抗瘤免疫力.
主要方法:
- 对CDK4/6表达,患者存活率和T细胞透的临床数据集的分析.
- 在Cdk4或Cdk6缺陷的小鼠模型中评估瘤生长.
- 研究DNA损伤和cGAS-STING通路的激活,以应对Cdk4/6缺陷.
- 在Sting淘汰赛模型中评估抗瘤效应.
主要成果:
- 瘤细胞中CDK4/6的缺陷显著降低了瘤的生长.
- Cdk4或Cdk6缺乏导致内源DNA损伤增加,激活cGAS-STING通路和I型干扰素反应.
- 斯廷淘汰赛部分或完全逆转了Cdk4/6缺乏的抗瘤作用.
结论:
- CDK4/6阻断通过一种依赖于STING的I型干扰素反应促进抗瘤免疫力.
- CDK4/6抑制剂可以通过促进先天性免疫信号传递来增强免疫疗法.
更多相关视频
07:21Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
相关概念视频
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
